Medical Marijuana Market Striking a CAGR of 35.4% by 2023 | Canopy Growth, Aurora Cannabis, Inc., Cannabis Sativa, Inc, GW Pharmaceuticals plc, etc | MRFR

Extensive Study of Medical Marijuana Market Research Report is Included on MarketResearchFuture.com with Latest Advancement. Detail analysis on possible segments and sub segments of the Medical Marijuana Market.

Medical Marijuana Market Global Overview:

Medical Marijuana Market is witnessing unprecedented growth due to its rapid proliferation in the healthcare sector. Its chemical component, known as cannabinoids, has medicinal properties which are gaining traction in pharmaceutical researches. The global medical marijuana market can expect a CAGR of 35.4% during the forecast period (2018-2023), reveals Market Research Future (MRFR) in an extensive study that includes market factors such as the detailed study of government initiatives, its increasing use in therapeutic applications. Rising cases of chronic diseases, and hike in investment by both private and government facilities regarding research. Furthermore, the report incorporates segmental analysis for a better understanding of the medical marijuana market in coming years.

On the flip side, stringent government policies can pull back the regular growth of the medical marijuana market. Its increasing recreational use may dampen its market prospect and jeopardize further growth.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6470

Topmost Players:

The key players profiled by MRFR that are operating in the global medical marijuana market are Canopy Growth, Aurora Cannabis, Inc., Cannabis Sativa, Inc, GW Pharmaceuticals plc, United Cannabis, MGC Pharma, Aphria, Inc., Tilray, Emerald Health Therapeutics [Canada] Inc., GBSciences, Inc., CanniMed Ltd., Medical Marijuana, Inc, Cara Therapeutics, and Greengro Technologies.

Segmentation:

The global medical marijuana market can be segmented by application, route of administration and distribution channel.

On the basis of application, the medical marijuana market includes Alzheimer’s disease, cancer, mental health conditions, multiple sclerosis, muscle spasms, glaucoma, and human immunodeficiency virus, acquired immunodeficiency syndrome (HIV/AIDS). Mental health conditions can further be segmented into schizophrenia and posttraumatic stress disorder (PTSD).

Based on the route of administration, the medical marijuana market can be segmented into oral, topical, inhalation and sublingual. The segment includes ointments, lotions, creams, gels, and poultice.

The medical marijuana market, by distribution channel, comprises dispensaries and online platforms.

Industry Updates:

In January 2019, it has been announced by the Arkansans Department of Health that the patients who are approved for purchasing medical; marijuana will receive patient cards by February 2019.

In January 2019, it has been announced that within next few days residents in Ohio will be able to purchase marijuana for medical purposes.

In January 2019, Trulieve, Florida's largest and first medical marijuana provider, has signed a deal to bring high-end edible marijuana products to Florida and will soon be made available for the registered medical marijuana patients in the form of cannabis chocolates, granola bars, honey, fruit leather, olive oil and more.

Medical Marijuana Market - Regional Analysis:

The market in the Americas is expected to dominate the global medical marijuana market during the forecast period owing to the increasing prevalence of chronic diseases, increasing number of cannabinoid drug approvals by regulatory authorities, and increasing expenditure on research and development of medical marijuana. The European market is expected to be the second-largest due to the favorable policies implemented by government and regulatory authorities and increasing applications of marijuana in healthcare. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing number of mental disorders and increasing expenditure on healthcare research and development. The market in the Middle East & Africa is likely to account for the smallest share of the global medical marijuana market. The market growth in this region can be attributed to the rising acceptance of medical marijuana in the treatment of illness and favorable government policies.

LIST OF TABLES:

Table 1 Global Medical Marijuana Market Synopsis, 2018–2023

Table 2 Global Medical Marijuana Market Estimates And Forecast, 2018–2023 (USD Million)

Table 3 Global Medical Marijuana Market, By Region, 2018–2023 (USD Million)

Table 4 Global Medical Marijuana Market, By Application, 2018–2023 (USD Million)

Table 5 Global Medical Marijuana Market, By Route Of Administration, 2018–2023 (USD Million)

Table 6 Global Medical Marijuana Market, By Distribution Channel, 2018–2023 (USD Million)

Table 7 North America: Medical Marijuana Market, By Application, 2018–2023 (USD

Million)

Table 8 North America: Medical Marijuana Market, By Route Of Administration, 2018–2023 (USD

Million)

Table 9 North America: Medical Marijuana Market, By Distribution Channel, 2018–2023 (USD

Million)

Table 10 US: Medical Marijuana Market, By Application, 2018–2023 (USD Million)

CONTINUED…!

Browse Complete 85 Pages Premium Research Report Enabled with Respective 30+ Tables and Figures at https://www.marketresearchfuture.com/reports/medical-marijuana-market-6470

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.